B lymphocytes as effector cells in the immunotherapy of cancer.
about
Vaccination with Melanoma Helper Peptides Induces Antibody Responses Associated with Improved Overall Survival.Whole-transcriptome analysis of flow-sorted cervical cancer samples reveals that B cell expressed TCL1A is correlated with improved survival.GIFT4 fusokine converts leukemic B cells into immune helper cellsThe thyroid status reprograms T cell lymphoma growth and modulates immune cell frequencies.An adaptive immune response driven by mature, antigen-experienced T and B cells within the microenvironment of oral squamous cell carcinoma.CP-25, a Novel Anti-inflammatory and Immunomodulatory Drug, Inhibits the Functions of Activated Human B Cells through Regulating BAFF and TNF-alpha Signaling and Comparative Efficacy with Biological Agents.Short leukocyte telomere length predicts poor prognosis and indicates altered immune functions in colorectal cancer patients.
P2860
Q30299957-DE76CEBF-436D-4EB4-9419-A2F8D7BC8C18Q36629387-A878697C-58A1-4F81-8530-A8AEFFE95C8BQ36842259-C14BBC36-D971-4725-9479-94617EDF6E33Q38819757-94FC28E7-28B0-48D3-8D6A-787390B64FE3Q40056727-7EAD4367-E255-44E6-B2D2-4998D66A9D8AQ47300233-F1B3547F-1AA6-497D-9FF9-B1A306EEC354Q54219261-2800A475-61BC-4BC8-9918-4A74EE9E34FA
P2860
B lymphocytes as effector cells in the immunotherapy of cancer.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
B lymphocytes as effector cells in the immunotherapy of cancer.
@en
B lymphocytes as effector cells in the immunotherapy of cancer.
@nl
type
label
B lymphocytes as effector cells in the immunotherapy of cancer.
@en
B lymphocytes as effector cells in the immunotherapy of cancer.
@nl
prefLabel
B lymphocytes as effector cells in the immunotherapy of cancer.
@en
B lymphocytes as effector cells in the immunotherapy of cancer.
@nl
P2093
P2860
P356
P1476
B lymphocytes as effector cells in the immunotherapy of cancer.
@en
P2093
Alfred E Chang
David M Lubman
Jianhui Zhu
Jintang He
Jukes P Namm
Shuang Wei
Xiangming Lao
P2860
P304
P356
10.1002/JSO.22093
P577
2011-09-06T00:00:00Z